Cost Of Inpatient Pediatric Type 1 Dıabetes Care In Turkey: Sıngle Center Experıence

Year 2021, Volume: 13 Issue: 2, 273 - 280, 07.06.2021

Eren Cam Mehmet Nurullah Kurutkan , İlknur Arslanoğlu , Okan Bütüner

https://doi.org/10.18521/ktd.774512

Abstract

Objective: To explore the financial cost of type 1 diabetic (T1D) children and adolescents during inpatient management for various reasons.

Method: Ten years of electronic hospital records (2009-2018) of the pediatric ward were screened retrospectively and hospitalizations with a confirmed diagnose of T1D were analyzed. Costs are grouped as laboratory tests, clinical interventions, drugs, medical supplies, and total costs before being converted to US dollars according to the mid-year index published by the Central Bank of Turkey. Descriptive statistics and comparisons against patient-specific characteristics are presented.

Results: There were 400 eligible cases. Cost per case for the hospital and for the Social Security Institution (SSI) were $268 and $309 respectively. The clinical intervention was the largest (49.84 vs 55.33 %) and that of medical supplies was the smallest (0.43 vs 0.55 %) component of the cost. Blood pH, HbA1c, having a single parent, and the number of days in the ward were parameters influencing total cost significantly (p<0.05).

Conclusion: The study offers the first data about pediatric T1D hospital stays in Turkey which are expected to help to reasonable resource distribution and efficiency of care.

Keywords

cost, type 1 diabetes, pediatric, inpatient, Turkey

Supporting Institution

-

Project Number

2018-53 Date of registration: 26.03.2018

References

• 1. American Diabetes Association. Economic costs of diabetes in the US in 2017. Diabetes care. 2018;41(5):917-928.
• 2. Centers for Disease Control and Prevention. National diabetes statistics report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
• 3. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabetic Med. 2006;23:857-66.
• 4. Stipancić G, La Grasta Sabolić L, Pozgaj Sepec M, Radica A, Skrabić V, Severinski S, Kujundzić Tiljak M. Regional differences in incidence and clinical presentation of type 1 diabetes in children aged under 15 years in Croatia. Croat Med J. 2012;53:141-8.
• 5. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G and EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. The Lancet. 2009;373:2027-33.
• 6. IDF Diabetes Atlas Country Report. 8th ed. Brussels:International Diabetes Federation; 2017.
• 7. Yeşilkaya E, Cinaz P, Andıran N, Bideci A, Hatun Ş, Sarı E et al. First report on the nationwide incidence and prevalence of Type 1 diabetes among children in Turkey. Diabetic Med. 2017;34:405-10.
• 8. YüksekÖğretim Kurulu Başkanlığı. Tez Merkezi. [cited 2020 July 19] https://tez.yok.gov.tr/UlusalTezMerkezi
• 9. https://dergipark.org.tr/tr/search?q=title%3A+%22cost+AND+diabetes+AND+Turkey%22&section=articles
• 10. Keskek SO, Kirim S, Yanmaz N, Keskek NS, Ortoglu G, Canataroglu A. Direct medical cost of type 1 and type 2 diabetes in Turkey. Int J Diabetes Dev C. 2014;34:77–81
• 11. Türkiye Diyabet Programı 2015-2020. Türkiye Halk Sağlığı Kurumu; 2014.
• 12. Mapa-Tassou C, Katte JC, Maadjhou CM, Mbanya JC. Economic Impact of Diabetes in Africa. Curr Diabetes Rep. 2019;19:5.
• 13. Cobas RA, Ferraz MB, Matheus ASDM, Tannus LRM, Negrato CA, Araujo LAD et al. The cost of type 1 diabetes: a nationwide multicentre study in Brazil. Bulletin of World Health Organization. 2013;91:434-40.
• 14. Ying AK, Lairson DR, Giardino AP, Bondy ML, Zaheer I, Haymond MW, Heptulla RA. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatr Diabetes. 2011;12:177-82.
• 15. Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD et al. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabetic Med. 2007;24:187-94.
• 16. Jasinski CF, Rodriguez-Monguio R, Tonyushkina K, Allen H. Healthcare cost of type 1 diabetes mellitus in new-onset children in a hospital compared to an outpatient setting. BMC Pediatrics. 2013;13:55.
• 17. Gray AM, Fenn P. The cost of insulin-dependent diabetes mellitus in England and Wales. Diabetic Med. 1995;12:1068-76.
• 18. Weinger K, Beverly EA, Lee Y, Sitnokov L, Ganda OP, Caballero AE. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial. Arch Intern Med. 2011;171:1990-9.